KALA |
KALA BIO, Inc. |
Jun 26, 2024 |
1 |
-$72K |
4 |
Jun 27, 2024 |
CHIEF EXECUTIVE OFFICER, Director |
AKRO |
Akero Therapeutics, Inc. |
Jun 8, 2024 |
1 |
$0 |
4 |
Jun 11, 2024 |
Director |
THRD |
Third Harmonic Bio, Inc. |
Jun 6, 2024 |
1 |
$0 |
4 |
Jun 10, 2024 |
Director |
AVTE |
Aerovate Therapeutics, Inc. |
Jun 5, 2024 |
1 |
$0 |
4 |
Jun 7, 2024 |
Director |
KALA |
KALA BIO, Inc. |
May 31, 2024 |
1 |
-$45K |
4 |
Jun 3, 2024 |
CHIEF EXECUTIVE OFFICER, Director |
MRUS |
Merus N.V. |
May 7, 2024 |
1 |
$0 |
4 |
May 9, 2024 |
Director |
QTTB |
Homology Medicines, Inc. |
Mar 25, 2024 |
1 |
$0 |
4 |
Mar 27, 2024 |
Director |
QTTB |
Homology Medicines, Inc. |
Mar 25, 2024 |
0 |
$0 |
3 |
Mar 27, 2024 |
Director |
KALA |
KALA BIO, Inc. |
Jan 4, 2024 |
3 |
-$30.5K |
4 |
Jan 5, 2024 |
CHIEF EXECUTIVE OFFICER, Director |
AKRO |
Akero Therapeutics, Inc. |
Jun 23, 2023 |
1 |
$0 |
4 |
Jun 27, 2023 |
Director |
KALA |
Kala Pharmaceuticals, Inc. |
Jun 22, 2023 |
2 |
$0 |
4 |
Jun 23, 2023 |
CHIEF EXECUTIVE OFFICER, Director |
MRUS |
Merus N.V. |
Jun 8, 2023 |
1 |
$0 |
4 |
Jun 12, 2023 |
Director |
AVTE |
Aerovate Therapeutics, Inc. |
Jun 6, 2023 |
1 |
$0 |
4 |
Jun 8, 2023 |
Director |
THRD |
Third Harmonic Bio, Inc. |
Jun 6, 2023 |
1 |
$0 |
4 |
Jun 8, 2023 |
Director |
KALA |
Kala Pharmaceuticals, Inc. |
May 31, 2023 |
11 |
$0 |
4 |
Jun 2, 2023 |
CHIEF EXECUTIVE OFFICER, Director |
MRUS |
Merus N.V. |
Apr 14, 2023 |
4 |
$535K |
4 |
Apr 17, 2023 |
Director |
KALA |
Kala Pharmaceuticals, Inc. |
Mar 14, 2023 |
1 |
$0 |
4 |
Mar 15, 2023 |
CHIEF EXECUTIVE OFFICER, Director |
THRD |
Third Harmonic Bio, Inc. |
Mar 6, 2023 |
4 |
$0 |
4 |
Mar 8, 2023 |
Director |
KALA |
Kala Pharmaceuticals, Inc. |
Jan 4, 2023 |
2 |
-$5.65K |
4 |
Jan 6, 2023 |
CHIEF EXECUTIVE OFFICER, Director |
KALA |
Kala Pharmaceuticals, Inc. |
Oct 26, 2022 |
1 |
-$3.66K |
4 |
Oct 28, 2022 |
CHIEF EXECUTIVE OFFICER, Director |
THRD |
Third Harmonic Bio, Inc. |
Oct 26, 2022 |
1 |
$0 |
4 |
Oct 27, 2022 |
Director |
THRD |
Third Harmonic Bio, Inc. |
Sep 14, 2022 |
0 |
$0 |
3 |
Sep 14, 2022 |
Director |
KALA |
Kala Pharmaceuticals, Inc. |
Jun 27, 2022 |
1 |
-$2.95K |
4 |
Jun 29, 2022 |
CHIEF EXECUTIVE OFFICER, Director |
AVTE |
Aerovate Therapeutics, Inc. |
Jun 21, 2022 |
1 |
$0 |
4 |
Jun 22, 2022 |
Director |
AKRO |
Akero Therapeutics, Inc. |
Jun 2, 2022 |
1 |
$0 |
4 |
Jun 3, 2022 |
Director |
MRUS |
Merus N.V. |
May 31, 2022 |
1 |
$0 |
4 |
Jun 2, 2022 |
Director |
KALA |
Kala Pharmaceuticals, Inc. |
Jan 3, 2022 |
2 |
-$12.4K |
4 |
Jan 5, 2022 |
CHIEF EXECUTIVE OFFICER, Director |
KALA |
Kala Pharmaceuticals, Inc. |
Oct 26, 2021 |
1 |
-$49.7K |
4 |
Oct 28, 2021 |
CHIEF EXECUTIVE OFFICER, Director |
AVTE |
Aerovate Therapeutics, Inc. |
Jun 29, 2021 |
0 |
$0 |
3 |
Jun 29, 2021 |
Director |
KALA |
Kala Pharmaceuticals, Inc. |
Jun 28, 2021 |
1 |
-$43.8K |
4 |
Jun 29, 2021 |
CHIEF EXECUTIVE OFFICER, Director |
AKRO |
Akero Therapeutics, Inc. |
Jun 1, 2021 |
1 |
$0 |
4 |
Jun 3, 2021 |
Director |
MRUS |
Merus N.V. |
May 28, 2021 |
1 |
$0 |
4 |
Jun 2, 2021 |
Director |
AVTE |
Aerovate Therapeutics, Inc. |
Apr 2, 2021 |
3 |
$0 |
4 |
Jul 1, 2021 |
Director |